{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:46:53Z","timestamp":1791056813663,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1023\/a:1006440430585","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:03:28Z","timestamp":1040522608000},"page":"205-213","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic Significance of p53 and p21WAF1\/CIP1 Immunoreactivity and Tumor Micronecrosis for Recurrence of Meningiomas"],"prefix":"10.1007","volume":"46","author":[{"given":"Yusuke","family":"Kamei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kanamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirou","family":"Waga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"262287_CR1","first-page":"449","volume-title":"Pathology of Tumours of the Nervous System","author":"GA Russel","year":"1989","unstructured":"Russel GA, Rubinstein LJ: Pathology of tumours of the nervous system. In: Russel GA, Rubinstein LJ (eds) Pathology of Tumours of the Nervous System. Williams & Wilkins, Baltimore, 1989, pp 449-532"},{"key":"262287_CR2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3171\/jns.1997.86.5.0793","volume":"86","author":"L Palma","year":"1997","unstructured":"Palma L, Celli P, Franco C, Cervoni L, Cantore G: Longterm prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86: 793-800, 1997","journal-title":"J Neurosurg"},{"key":"262287_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00312803","volume":"208","author":"K Jellinger","year":"1975","unstructured":"Jellinger K, Slowik F: Histological subtypes and prognostic problems in meningiomas. J Neurol 208: 279-298, 1975","journal-title":"J Neurol"},{"key":"262287_CR4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/00000478-198612000-00002","volume":"10","author":"SM Dela Monte","year":"1986","unstructured":"Dela Monte SM, Flickinger J, Linggood RM: Histopathological features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 10: 836-843, 1986","journal-title":"Am J Surg Pathol"},{"key":"262287_CR5","first-page":"74","volume":"9","author":"WY Chen","year":"1990","unstructured":"Chen WY, Liu HC: Atypical (anaplastic) meningioma: relationship between histological features and recurrence-clinicopathologioal study. Clin Neuropathol 9: 74-81, 1990","journal-title":"Clin Neuropathol"},{"key":"262287_CR6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","volume":"62","author":"RO Mirimanoff","year":"1985","unstructured":"Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL: Meningioma: Analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62: 18-24, 1985","journal-title":"J Neurosurg"},{"key":"262287_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005072-199405000-00005","volume":"53","author":"DW Hsu","year":"1994","unstructured":"Hsu DW, Pardo FS, Efird JT, Linggood RM, Hedley-Whyte ET: Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 53: 247-255, 1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"262287_CR8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF02187190","volume":"137","author":"H Kolles","year":"1995","unstructured":"Kolles H, Niedermayer I, Schmitt CH, Henn W, Feld R, Stendel WI, Zang KD, Feiden W: Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67\/Feulgen staining and cytogenetics. Acta Neurochir 137: 174-181, 1995","journal-title":"Acta Neurochir"},{"key":"262287_CR9","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1097-0142(19861001)58:7<1466::AID-CNCR2820580715>3.0.CO;2-W","volume":"58","author":"T Hoshino","year":"1986","unstructured":"Hoshino T, Nagashima T, Murovic JA, Wilson CB, Davis RL: Proliferative potential of human meningiomas of the brain: A cell kinetics study with bromodeoxyuridine. Cancer 58: 1466-1472, 1986","journal-title":"Cancer"},{"key":"262287_CR10","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/1097-0142(19940415)73:8<2200::AID-CNCR2820730827>3.0.CO;2-6","volume":"73","author":"K Kunishio","year":"1994","unstructured":"Kunishio K, Ohmoto T, Matsuhisa T, Maeshiro T, Furuta T, Matsumoto K: The significance of nuclear organizer region (AgNOR) score in predicting meningioma recurrence. Cancer 73: 2200-2205, 1994","journal-title":"Cancer"},{"key":"262287_CR11","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/1097-0142(19941215)74:12<3176::AID-CNCR2820741217>3.0.CO;2-N","volume":"74","author":"M Ohta","year":"1994","unstructured":"Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M: MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer 74: 3176-3189, 1994","journal-title":"Cancer"},{"key":"262287_CR12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0046-8177(96)90107-0","volume":"27","author":"LA Langford","year":"1996","unstructured":"Langford LA, Cooksley CS, DeMonte F: Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 27: 350-354, 1996","journal-title":"Hum Pathol"},{"key":"262287_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(91)90636-D","volume":"64","author":"JM Bishop","year":"1991","unstructured":"Bishop JM: Molecular themes in oncogenesis. Cell 64: 235-248, 1991","journal-title":"Cell"},{"key":"262287_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane DP: Cancer. p53, guardian of the genome. Nature 358: 15-16, 1992","journal-title":"Nature"},{"key":"262287_CR15","first-page":"R43","volume":"1378","author":"N Almog","year":"1998","unstructured":"Almog N, Rotter V: An insight into the life of p53: a protein coping with many functions! Review of the 9th p53 Workshop, Crete, May 9-13, 1998. Biochem Biophys Acta 1378: R43-R54, 1998","journal-title":"Biochem Biophys Acta"},{"key":"262287_CR16","first-page":"4855","volume":"54","author":"MS Greenblatt","year":"1994","unstructured":"Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994","journal-title":"Cancer Res"},{"key":"262287_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/mc.2940080203","volume":"8","author":"H Ohgaki","year":"1993","unstructured":"Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Petersen I, Holl T, Wiestler OD, Kleihues P: Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinogenesis 8: 74-80, 1993","journal-title":"Mol Carcinogenesis"},{"key":"262287_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ijc.2910640402","volume":"64","author":"J-L Wang","year":"1995","unstructured":"Wang J-L, Zhang Z-J, Hartman M, Smits A, Westermark B, Muhr C, Nister M: Detection of TP53 mutation in human meningiomas: A study using immunohistochemistry, polymerase chain reaction\/single-strand conformation polymorphism andDNAsequencing techniques on paraffin-embedded samples. Int J Cancer 64: 223-228, 1995","journal-title":"Int J Cancer"},{"key":"262287_CR19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/ajcp\/106.6.776","volume":"106","author":"A Matsuno","year":"1996","unstructured":"Matsuno A, Nagashima T, Matsuura R, Tanaka H, Hirakawa M, Murakami M, Tamura A, Kirino T: Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106: 776-781, 1996","journal-title":"Am J Clin Pathol"},{"key":"262287_CR20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/ajcp\/105.6.719","volume":"105","author":"RA Prayson","year":"1996","unstructured":"Prayson RA: Malignant meningioma: A clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry. Am J Clin Pathol 105: 719-726, 1996","journal-title":"Am J Clin Pathol"},{"key":"262287_CR21","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R","volume":"82","author":"A Perry","year":"1998","unstructured":"Perry A, Stafford SL, Scheithauser BW, Suman VJ, Lohse CM: The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82: 2262-2269, 1998","journal-title":"Cancer"},{"key":"262287_CR22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0046-8177(98)90224-6","volume":"29","author":"E Karamitopoulou","year":"1998","unstructured":"Karamitopoulou E, Perentes E, Tolnay M, Probst A: Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29: 140-145, 1998","journal-title":"Hum Pathol"},{"key":"262287_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1005946001915","volume":"38","author":"M Ohkoudo","year":"1998","unstructured":"Ohkoudo M, Sawa H, Hara M, Saruta K, Aiso T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saito I: Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas. J Neurooncol 38: 41-49, 1998","journal-title":"J Neurooncol"},{"key":"262287_CR24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS El-Deiry","year":"1993","unstructured":"El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993","journal-title":"Cell"},{"key":"262287_CR25","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1101\/gad.8.15.1750","volume":"8","author":"H Zhang","year":"1994","unstructured":"Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Develop 8: 1750-1758, 1994","journal-title":"Genes Develop"},{"key":"262287_CR26","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-84988-6","volume-title":"Histological Typing of Tumors of the Central Nervous System","author":"P Kleihues","year":"1993","unstructured":"Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System. 2nd edn., Springer-Verlag, Berlin, 1993","edition":"2nd edn."},{"key":"262287_CR27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1097-0142(19860715)58:2<299::AID-CNCR2820580215>3.0.CO;2-W","volume":"58","author":"B Pasquier","year":"1986","unstructured":"Pasquier B, Gasnier F, Pasquier D, Keddari E, Morens A, Couderc P: Papillary meningioma, clinicopathologic study of seven cases and review of the literature. Cancer 58: 299-305, 1986","journal-title":"Cancer"},{"key":"262287_CR28","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/00000478-199812000-00005","volume":"22","author":"A Perry","year":"1998","unstructured":"Perry A, Scheithauer BW, Stafford SL, Abell-Aleff PC, Meyer FB: 'Rhabdoid' meningioma: An aggressive variant. Am J Surg Pathol 22: 1482-1490, 1998","journal-title":"Am J Surg Pathol"},{"key":"262287_CR29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000478-199505000-00001","volume":"19","author":"S Zorludemir","year":"1995","unstructured":"Zorludemir S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer FB: Clear cell meningioma.Aclinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol 19: 493-505, 1995","journal-title":"Am J Surg Pathol"},{"key":"262287_CR30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3171\/jns.1992.77.4.0616","volume":"77","author":"H Maier","year":"1992","unstructured":"Maier H, Ofner D, Hittmair A, Kitz K, Budka H: Classic, atypical, and anaplastic meningioma: Three histological subtypes of clinical relevance. J Neurosurg 77: 616-623, 1992","journal-title":"J Neurosurg"},{"key":"262287_CR31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s002920050226","volume":"18","author":"I Niedermayer","year":"1997","unstructured":"Niedermayer I, Kolles H, Henn W, Zang KD, Steudel WI, Feiden W: Meningioma. Classification and grading. Patholog 18: 353-358, 1997","journal-title":"Patholog"},{"key":"262287_CR32","first-page":"330","volume":"15","author":"I Niedermayer","year":"1996","unstructured":"Niedermayer I, Kolles H, Zang KD, Feiden W: Characterization of intermediate type (WHO 'atypical') meningiomas. Clin Neuropathol 15: 330-336, 1996","journal-title":"Clin Neuropathol"},{"key":"262287_CR33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00006123-199304000-00023","volume":"32","author":"PM Black","year":"1993","unstructured":"Black PM: Meningiomas. Neurosurgery 32: 643-657, 1993","journal-title":"Neurosurgery"},{"key":"262287_CR34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3171\/jns.1994.81.5.0666","volume":"81","author":"CB Wilson","year":"1994","unstructured":"Wilson CB: Meningiomas: genetic, malignancy, and the role of radiation in induction and treatment. J Neurosurg 81: 666-675, 1994","journal-title":"J Neurosurg"},{"key":"262287_CR35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s007010050398","volume":"141","author":"J Ayerbe","year":"1999","unstructured":"Ayerbe J, Lobato RD, de la Cruz J, Alday R, Rivas JJ, Gomez PA, Cabrera A: Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wien) 141: 921-932, 1999","journal-title":"Acta Neurochir (Wien)"},{"key":"262287_CR36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4065\/73.10.936","volume":"73","author":"SL Stafford","year":"1998","unstructured":"Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG: Primary resected meningiomas: Outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73: 936-942, 1998","journal-title":"Mayo Clin Proc"},{"key":"262287_CR37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3171\/jns.1986.64.1.0058","volume":"64","author":"B Borovich","year":"1986","unstructured":"Borovich B, Doron Y: Recurrence of intracranial meningiomas: The role played by regional multicentricity. J Neurosurg 64: 58-63, 1986","journal-title":"J Neurosurg"},{"key":"262287_CR38","first-page":"241","volume":"39","author":"G Mariniello","year":"1995","unstructured":"Mariniello G, Spaziante R, Cappabianca P, Donzelli R, Del Basso de Caro ML, De Divitiis E: Multicentrical growth of meningiomas: 'spatial' or 'temporal' phenomenon. J Neurosurg Sci 39: 241-247, 1995","journal-title":"J Neurosurg Sci"},{"key":"262287_CR39","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","volume":"21","author":"A Perry","year":"1997","unstructured":"Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: Meningioma grading: An analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465, 1997","journal-title":"Am J Surg Pathol"},{"key":"262287_CR40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2559.1993.tb01218.x","volume":"23","author":"CA McLean","year":"1993","unstructured":"McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF: Atypical and malignant meningiomas: Importance of micronecrosis as a prognostic indicator. Histopathology 23: 349-353, 1993","journal-title":"Histopathology"},{"key":"262287_CR41","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(98)90010-7","volume":"29","author":"CM Abramovich","year":"1998","unstructured":"Abramovich CM, Prayson RA: MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors. Hum Pathol 29: 1420-1427, 1998","journal-title":"Hum Pathol"},{"key":"262287_CR42","first-page":"1395","volume":"13","author":"J Chen","year":"1996","unstructured":"Chen J, Willingham T, Shuford M, Bruce D, Rushing E, Smith Y, Nisen PD: Effects of ectopic overexpression of p21(WAF1\/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells. Oncogene 13: 1395-1403, 1996","journal-title":"Oncogene"},{"key":"262287_CR43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/bjc.1996.339","volume":"74","author":"M Barbareschi","year":"1996","unstructured":"Barbareschi M, Caffo O, Doglioni C, Fina P, Marchetti A, Buttitta F, Leek R, Morelli L, Leonardi E, Bevilacqua G, Dalla Palma P, Harris AL: p21(WAF1) immunohistochemical expression in breast carcinoma: Correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br J Cancer 74: 208-215, 1996","journal-title":"Br J Cancer"},{"key":"262287_CR44","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<372::AID-CNCR4>3.0.CO;2-U","volume":"80","author":"ST Dergham","year":"1997","unstructured":"Dergham ST, Dugan MC, Joshi US, Chen YC, Du W, Smith DW, Arlauskas P, Crissman JD, Vaitkevicius VK, Sarkar FH: The clinical significance of p21 (WAF1\/CIPl) and p53 expression in pancreatic adenocarcinoma. Cancer 80: 372-381, 1997","journal-title":"Cancer"},{"key":"262287_CR45","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s004010050848","volume":"95","author":"P Korkolopoulou","year":"1998","unstructured":"Korkolopoulou P, Kouzelis K, Christodoulou P, Papanikolaou A, Thomas-Tsagli E: Expression of retinoblastoma gene product and p21(WAF1\/Cip1) protein in gliomas: Correlations with proliferation markers, p53 expression and survival. Acta Neuropathol (Berl) 95: 617-624, 1998","journal-title":"Acta Neuropathol (Berl)"},{"key":"262287_CR46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1006149021810","volume":"40","author":"YJ Li","year":"1998","unstructured":"Li YJ, Hoang-Xuan K, Zhou XP, Sanson M, Mokhtari K, Faillot T, Cornu P, Poisson M, Thomas G, Hamelin R: Analysis of the p21 gene in gliomas. J Neuro-Oncol 40: 107-111, 1998","journal-title":"J Neuro-Oncol"},{"key":"262287_CR47","first-page":"2021","volume":"11","author":"J-M Jung","year":"1995","unstructured":"Jung J-M, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, Levin VA, Zhang W: Increased levels of p21(WAF1\/Cip1) in human brain tumors. Oncogene 11: 2021-2028, 1995","journal-title":"Oncogene"},{"key":"262287_CR48","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/bjc.1995.491","volume":"72","author":"J Koopmann","year":"1995","unstructured":"Koopmann J, Maintz D, Schild S, Schramm J, Louis DN, Wiestler OD, von Deimling A: Multiple polymorphisms, but no mutations, in the WAF1\/CIP1 gene in human brain tumors. Br J Cancer 72: 1230-1233, 1995","journal-title":"Br J Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006440430585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006440430585\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006440430585.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:17:29Z","timestamp":1749633449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006440430585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["262287"],"URL":"https:\/\/doi.org\/10.1023\/a:1006440430585","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}